Abstract
To assess the peripheral vascular effects of estrogen in women without coronary disease, normal postmenopausal women (mean age 56 ± 8 years) participated in a randomized, crossover trial using treadmill exercise echocardiography, and received oral conjugated estrogen, 0.625 mg/day or underwent a drug-free period. There was no significant effect on heart rate, blood pressure, double product, left ventricular end-systolic and end- diastolic diameters, or electrocardiographic measures after estrogen. In contrast to the profound effects reported in patients with cardiac disease, oral estrogen in normal women does not bestow significant benefit on treadmill exercise echocardiographic variables at rest or during modest levels of exercise.
Original language | English |
---|---|
Pages (from-to) | 793-797 |
Number of pages | 5 |
Journal | American Journal of Cardiology |
Volume | 80 |
Issue number | 6 |
DOIs | |
Publication status | Published - Sept 15 1997 |
Bibliographical note
Funding Information:This study was supported in part by Grant HL-07406 from the Department of Health and Human Services, Bethesda, Maryland, Grant RR-00645 from the Research Resources Administration, Bethesda, Maryland, and a Grant from Linda and Peter Nisselson.
Funding
This study was supported in part by Grant HL-07406 from the Department of Health and Human Services, Bethesda, Maryland, Grant RR-00645 from the Research Resources Administration, Bethesda, Maryland, and a Grant from Linda and Peter Nisselson.
Funders | Funder number |
---|---|
Research Resources Administration | |
U.S. Department of Health and Human Services | RR-00645 |
National Center for Research Resources | M01RR000645 |
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine